Akari Therapeutics (AKTX) EPS (Basic) Growth (5y) (2019 - 2025)
Akari Therapeutics (AKTX) EPS (Basic) Growth (5y) (2019 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - |
| 10 | Regeneron Pharmaceuticals | 63.59 Bn | 54.83 Bn | 3.31 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -216.17% |
| Sep 30, 2025 | -8.11% |
| Jun 30, 2025 | 52.77% |
| Mar 31, 2025 | 48.95% |
| Dec 31, 2024 | 48.30% |
| Sep 30, 2024 | 37.31% |
| Jun 30, 2024 | 34.26% |
| Mar 31, 2024 | -122.97% |
| Dec 31, 2020 | -20.11% |
| Sep 30, 2020 | 74.01% |
| Jun 30, 2020 | 41.02% |
| Mar 31, 2020 | 0.43% |
| Dec 31, 2019 | 15.64% |
| Sep 30, 2019 | 12.37% |
| Jun 30, 2019 | 37.60% |
| Mar 31, 2019 | 14.87% |